Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

A More Modern ResearchKit Alternative For Study Developers
  • USA - English


News provided by

Crucial Data Solutions, Inc

Dec 19, 2017, 06:00 ET

Share this article

Share toX

Share this article

Share toX


The biggest difference between the two technologies, is 98 percent of what is needed to conduct regulatory compliant research is available out of the box with TrialKit. With ResearchKit, that must all be developed from scratch...

Post this

RENO, and TAHOE, Nev. (PRWEB) December 19, 2017 -- In 2015 Apple launched ResearchKit® - a powerful tool to deploy clinical research in a mobile world. Up until about six months ago, Apple’s ResearchKit was the only sound and high tech option if you wanted to conduct clinical research in a strictly native mobile environment. In May of 2017, Crucial Data Solutions, Inc. (CDS) released TrialKit™ - designed to eliminate the need for software and database developers, while at the same time creating entirely regulatory compliant research studies that run on 99 percent of the world’s smartphones and tablets.

Below, we compare the capabilities of the two systems:

TrialKit:
Requires software developer(s)? No, anybody can build advanced studies
Builds regulatory compliant research studies? Yes
Cost (US$)? $499 per month; no cost for changes
Available platforms / percent of mobile devices? iOS and Android / 98%
Fully utilizes device technology, including: geo-positioning, accelerometer, gyroscope, HealthKit™, push notification service, Apple Watch®, Android Watch, cameras? Yes
Full website support? Yes
Number of studies accessible from app? Unlimited
Native support for all clinical roles (site coordinator, investigator, monitor, data manager, medical coder, study builder, custom roles)? Yes
Study changes require app resubmission? No
Certified by MedDRA and WHODrug for medical coding? Yes
Free training and tech support? Yes
Fully developed using Xcode® and Android Studio? Yes

ResearchKit:
Requires software developer(s)? Yes
Builds regulatory compliant research studies? No
Cost (US$)? 5 to 7 figures; additional for changes
Available platforms / percent of mobile devices? iOS / 38%
Fully utilizes device technology, including: geo-positioning, accelerometer, gyroscope, HealthKit™, push notification service, Apple Watch®, Android Watch, cameras? Yes/some studies
Full website support? No
Number of studies accessible from app? One
Native support for all clinical roles (site coordinator, investigator, monitor, data manager, medical coder, study builder, custom roles) No
Study changes require app resubmission? Yes
Certified by MedDRA and WHODrug for medical coding? No
Free training and tech support? No
Fully developed using Xcode® and Android Studio? Yes - only Xcode

TrialKit has greatly eased the process of building, deploying, and managing clinical research studies. Simply download the app, complete five fields, and you have a fully functioning system. From the TrialKit website, you can sign up for free instructor-based training. CDS recommends everybody take a 30 minute orientation course, but users have access to as much training as they need from certified instructors with a tremendous understanding of clinical research.

Once you have registered, you can create your first study in minutes. That first study contains a powerful set of defaults and even sample case report forms complete with advanced business logic and other items that will make your study regulatory compliant.

With ResearchKit, the first step is to download Xcode. If you are not a software developer, then really the first step is to go out and hire one. iOS developers do not come inexpensively and there are literally thousands of iOS developer job openings, so this step may be more difficult than you expect. Certainly, it will be a spendy endeavor. Of course, that is only to develop a UI; you will need additional developers to create a regulatory compliant WebAPI and model a regulatory compliant database and tie it all together.

With TrialKit, this all comes in the box. TrialKit is the next logical progression of a web-based eClinical system named Clinical Studio. The developers at CDS have been creating tools that allow medical professionals to build their own studies for decades. TrialKit has an incredible drag-and-drop interface for doing virtually everything. In addition, TrialKit is so highly configurable that you can create very simple survey studies on up to the world’s most complex oncology studies.

Within the clinical research industry, TrialKit is the only complete eClinical system developed as a native mobile app in both iOS and Android. If you want to see how it stacks up against the leaders, CDS publishes an exhaustive list of eClinical features along with two leading systems:

http://www.trialkit.com/wp-content/uploads/Competitive-System-Comparison-PDF.pdf

We asked CDS President Paul Grady why ResearchKit was not included in this comparison. Although very reserved, he had this to say, “ResearchKit is a software development environment and out of the box has literally no features. They have to be developed almost completely from scratch. We did not feel as though it would be fair to publish what ResearchKit can do out of the box. In addition, ResearchKit is not targeted to be a 21 CFR Part 11 compliant environment, which means technically it is not an eClinical system.”

Ironically, Grady went on to explain that CDS implemented into TrialKit several excellent ideas that came as suggestions from the ResearchKit team. He went on to compliment many of the studies that have been done in ResearchKit, but cautioned sponsors by saying this: “ResearchKit studies are excellent. They tap into some very important technology that is part of today’s mobile devices. However, TrialKit - through activity testing technology - can implement the same types of diagnostic procedures. Once added to TrialKit as an activity test, the diagnostic procedure can be then added to any study in a protocol compatible visit CRF. The biggest difference between the two technologies, is 98 percent of what is needed to conduct regulatory compliant research is available out of the box with TrialKit. With ResearchKit, that must all be developed from scratch, which makes ResearchKit cost prohibitive to all but the most wealthy companies.”

We asked Grady if, in his opinion, TrialKit makes ResearchKit obsolete. He responded, “No, we do not feel as though that is the case. It is obsolete if you are not a huge research organization, because you simply cannot afford it. The two technologies could work side by side one day, who knows? My biggest concern is if you can conduct a research study for X with TrialKit, why would anybody pay 100X to conduct the same study with ResearchKit? We feel as though that really inflates the overall cost of research and, as a result, the overall cost of healthcare which will be detrimental to future research and healthcare subscribers.”

About Crucial Data Solutions, Inc.
Crucial Data Solutions, Inc. is a forward-thinking company dedicated to developing innovative technologies that reduce the cost of medical research by equipping clinical professionals with the tools they need to advance treatments that enable patients with life-altering conditions to lead better lives. We believe clinical research should be a true partnership between ourselves, research professionals, caregivers, and patients worldwide.

Android is a trademark of Google LLC.

Public Relations, Crucial Data Solutions, Inc, http://www.trialkit.com, +1 888-753-2655, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.